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~or a better understanding of the pathogenetic events opera-
tive in the cutaneous manifestations of human immunodefi-
ci~ncy virus type 1 (HIV -1) disease, we investigated whether 
epidermal cells (EC) from HIV -1- seronegative persons can 
be infected with HIV -1 and, vice versa, whether HIV -1 can 
be rescued from the epidermis of HIV -1 - infected individu-
als. 
In a series of three experiments, we consistently found that 
exposure of EC from HIV -1- seronegative donors to HIV-1 
led to viral replication in these cells as evidenced by the 
detection of HIV-1 p24 in culture fluids. Because EC had 
be~n substantially enriched for Langerhans cells (LC) before 
beIng exposed to HIV -1, it is reasonable to assume that these 
CD1a+ /CD4+ /MHC class n+ antigen-presenting cells of 
the epidermis represented the actual targets of infection. This 
assumption is further strengthened by the observation that T 
cell_ depleted cell suspensions from Langerhans cell histio-
cytosis (LCH) lesions could be productively infected with 
BIV-l. 
T he human immunodeficiency virus type 1 (HIV-l), the causative agent of the acquired immunodeficiency syndrome (AIDS), is known to infect a variety of tar-get cell types in vivo including T lymphocytes, mono-nuclear phagocytes (MNP), and oligodendrocytes. 
!he major route of entry of HIV -1 into these targets occurs via an 
Interaction between the virus envelope gp120 and the gp120-bind-
illg Site of CD4 [1 - 5) , a surface moiety primarily found on T lym-
phOcytes and MNP [6] . 
Conversely, co-culture of epidermal sheets from HIV-1-
seropositive individuals with mononuclear phagocytes 
(MNP) from HIV -1- seronegative donors resulted, after 3 to 
5 weeks, in the detection of HIV-1 p24 in 12 of 23 cases. 
Immunocytochemical analysis, using a monoclonal antibody 
specific for p24, revealed the presence ofHIV-1 in adherent 
MNP in three co cultures tested. In addition, cellular DNA 
from these cultures showed strong signals when hybridized 
to a HIV-1-specific DNA probe. 
The further finding that two isolates examined exhibited 
different restriction enzyme patterns indicates that they are 
separate entities rather than contaminants. Transmission of 
these isolates to MNP, B- or T-cell lines resulted in cultures 
strongly positive for p24 and, in the case of H9 cells, for viral 
particles as detected by electron microscopy. 
Our results therefore strongly suggest that EC not only can 
serve as targets for HIV -1, but also can allow efficient virus 
replication and transmit HIV -1 to various cell types of the 
hematopoietic lineage. ] Invest Dermatol 99:271-277, 1992 
Among epidermal cells (EC) , CDla+ jCD4+ jCD32+ jmajor his-
tocompatability complex (MHC) class II - bearing Langerhans cells 
(LC) represent a putative target cell population for HIV -1. In fact, 
there exists some evidence suggesting that this may be the case. In 
1984, Belsito et al reported that AIDS-related complex (ARC)j 
AIDS patients have reduced numbers of Ia+ j ATPase+ epidermal 
dendritic cells [7] . Using immunofluorescence double-labeling tech-
niques, Tschachler et al [8) detected CDla+ jHIV-l p17+ dendritic 
epidermal cells in skin biopsies of some HIV -1- infected persons. 
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brevlatlons: 
AIDS: acquired immunodeficiency syndrome 
ARC: AIDS-related complex 
ATPase: adenosine triphosphatase 
ERY: Epstein-Barr virus 
EC: epidermal cells 
ELISA: enzyme-linked immunosorbent assay 
HIV-1: human immunodeficiency virus type 1 
IL-1: interleukin 1 
IL-6: interleukin 6 
LC: Langerhans cells 
LCH: Langerhans cell histiocytosis 
L TR: long terminal repeat(s) 
MHC: major histocompatibility complex 
MoAb: monoclonal antibody 
MNC: mononuclear cells 
MNP: mononuclear phagocytes 
PBS-BSA: phosphate-buffered saline-bovine serum albumin 
RT: reverse transcriptase 
tat: transactivating protein 
TGF-a: transforming growth factor alpha 
TNF-a: tumor necrosis factor alpha 
0022-202X!92!SOS .00 Copyright © 1992 by The Society for Investigative Dermatology, Inc. 
271 
272 BERGER ET AL 
Ultrastructural analysis of one of these biopsies revealed the pres-
ence of retroviral particles in intercellular spaces between LC and 
keratinocytes and budding of such a particle from LC membranes 
[9] . More recently, Leonard et al constructed HIV-l long terminal 
repeat (L TR) transgenic mice and found the transgene to be prefer-
ential ly expressed in LC [10] . 
In contrast to these findings, other authors were not successful 
when searching for the presence of HIV -1 in EC/LC of HIV -1-
infected persons [11,12]. 
This study was undertaken to address this controversial issue. In 
particular, we asked whether EC can be infected by HIV -1 in vitro 
and, conversely, whether HIV -1 can be rescued from the epidermis 
of HIV -1 - infected persons. 
MATERIALS AND METHODS 
Cell Lines H9 and Molt-3 are CD4-positive T -cell lines [13,14]; 
the L929 cell line is derived from mouse fibroblasts [American Type 
Culture Collection (ATCC) CCL#l]. R588-3 is an Epstein-Barr 
virus (EBV) - positive Iymphoblastoid B-ceilline established by one 
of us (RB). Cells were maintained at 3TC, 5% CO2 in RPMI 1640 
supplemented with 20% heat-inactivated FCS, 2 mM L-glutamine, 
and 50.ug/ml penicillin-streptomycin (all reagents obtained 
through Gibco, Paisley, UK) and split 1:4 every 3-4 d. 
Viruses As a source of exogenous HIV -1, we used the strains 
HIV-1111B [14], and HIV-lwR_sK/86 [9]. Virus stocks were grown in 
H9 cells (HIV -1 111B) or MNP (HIV -lwR-sK/86) and stored as cell-free 
supernatants at -80°C. 5 X 106 cells (primary cells or cell lines) and 
cell-free culture supernatants that contained virus equivalent to 
100,000 cpm reverse transcriptase (RT) were incubated for 1 hat 
37 ° C. Cells were washed three times in serum-free medium (RPMI 
1640) before -onset of cultures. 
Isolation of Peripheral Blood Mononuclear Cells (MNC) and 
MNP MNC were isolated from heparinized peripheral blood of 
healthy donors (HIV -1 seronegative) by density-gradient centrifu-
gation using Lymphoprep (Nycomed, Oslo, Norway). MNC were 
enriched for MNP by plastic adherence. For this purpose, 8 X 107 
MNC were cultured in 10 ml RPMI 1640 medium containing 20% 
heat-inactivated fetal calf serum, 2 mM L-glutamine, 50.ug/ml 
penicillin-streptomycin, and 10% heat-inactivated human AB 
serum (Flow Laboratories, Irvine, UK) in 25-cm2 flasks (Nunc A.S., 
Roskilde, Denmark). After an incubation period of 24 h at 37°C, 
5% CO2 , adherent MNP, which comprised 25-35% of the input 
cell number, were washed three times with phosphate-buffered sa-
line (PBS, 37 °C) to remove non-adherent cells and maintained in 
the presence of the medium described earlier (without human AB 
serum) for 5 - 7 d before using them in co-cultures. For certain 
experiments, the cells of the non-adherent fraction were cultured in 
the presence of 5 .ug/ml PHA-M (Sigma, St. Louis, MO) for 48 h 
and then used as targets for HIV-l. 
Epidermal Sheets Six-millimeter punch-biopsy specimens were 
obtained from non-lesional (n = 16) or lesional (n = 7) skin of 
HIV-l-seropositive persons (n = 23) or healthy controls (n = 20, 
HIV-l seronegative). Biopsies were transferred to 24-well plates 
(Costar, Cambridge, MA) containing 2 ml serum-free RPM I 1640 
medium per well plus dispase (2 U Iml; Boehringer-Mannheim, 
FRG) and incubated for 2 h at 3TC. Epidermal sheets were then 
peeled from the dermis with forceps and rinsed five times in serum-
free RPMl 1640 before use in co-culture experiments. 
Co-Cultures Between Epidermal Sheets and MNP Epider-
mal sheets were cut into small pieces and cultured in 25-cm2 culture 
flasks on a layer of MNP isolated as described above. The culture 
medium (RPMI 1640 plus 20% FCS, 2 mM L-glutamine, 50 .ug/ml 
penicillin-streptomycin) containing pieces of the epidermal sheets 
was completely replaced after the first 7 d and cultures were then fed 
every 7 d by replacing 50% of the culture medium. 
Detection ofHIV-l in Culture Supernatants Culture super-
natants were harvested at weekly intervals and screened for virus 
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production by an indirect ELISA specific for HIV -1 p24 (Coulter 
Electronics, Hialey, FL). HIV -1 replication was monitored for at 
least 10 weeks and cultures were considered positive if p24 increased 
threefold above background during subsequent assays. 
Epidermal Cell Suspensions Epidermal cells (EC) were 
enriched for LC essentially as described before [15]. Briefly, epider-
mal sheets were prepared from keratomed skin using dispase (2 
U/ml, Boehringer-Mannheim, Mannheim, FRG) for 1 hat 3TC 
followed by a short incubation (10 min, 37°C) on a 0.25% trypsin/ 
PBS solution and subsequent treatment with 0.025 deoxyribonu-
clease I (Sigma, St. Louis, MO) for 30 min at room temperature. 
The sheets were then disaggregated by vigorous stirring and the 
resulting cell suspension was filtered through a sterile nylon gauze 
sieve to remove cell clumps. To enrich for LC, cells were incubated 
for 1 h at 37°C in collagen-coated (Vitrogen 100, Collagen Corp., 
Palo Alto, CAl culture flasks and a large percentage of the remain-
ing keratinocytes in the non-adherent fraction was killed by resu-
spension and vortexing in ice-cold PBS for 2 min. Dead cells were 
removed by density centrifugation and both the quality and the 
efficiency of the enrichment procedure were analyzed by indirect 
immunofluorescence using monoclonal antibodies (MoAb) OKT6 
(anti-CDla, Ortho, Raritan, NJ), OKT3 (anti-CD3, Ortho, Rari-
tan, NJ), and KiM8 (Behring AG, Marburg, FRG). 5 X 106 cellsl 
well were maintained in 6-well plates (Nunc A.S., Roskilde, Den-
mark) in RPMI 1640 medium containing 10% heat-inactivated 
FCS, 2 mM L-glutamine, and 50 .ug/ml penicillin-streptomycin. 
Enrichment ofCDla+ Cells Derived from Langerhans Cell 
Histiocytosis (LCH) Lesions by Negative. Selection Biopsy 
material from osseous LCH lesions was incubated in RPMI 1640 
medium containing dispase/collagenase (2 U Iml, Boehringer-
Mannheim, FRG) for 2 h at 37°C. Single cell suspensions were 
obtained by mincing the tissue through a stainless steel mesh. After a 
single wash in serum-free RPMI 1640, cells were incubated with a 
mixture of anti-CD2 (Leu 5b, Becton Dickinson, Mountain View, 
CAl and anti-CD3 (Leu 4) MoAb (10 .ug/ml), and the reactive cells 
(i.e., T lymphocytes) were then removed with goat-anti-mouse 
IgG-coated magnetic beads (Dynal, Oslo, Norway) essentially as 
described [16] . The remaining non-reactive cells (80-85% CD1a+, 
negative for OKT 3, and KiM8 antigen) were resuspended in RPMI 
1640 supplemented as described above and plated at a cell density of 
5 X 106/well in 6-well plates (Nunc A.S ., Roskilde, Denmark). 
Immunocytochemistry MNP were cultured in slide-flasks 
(Nunc, A.S., Roskilde, Denmark) for 1 week before inoculation 
with cell-free culture supernatants from p24-positive co-cultures. 
Three to four weeks after infection, cells were fixed in acetone and 
processed for immunocytochemical staining. Slides were incubated 
for 2 h at room temperature with a MoAb reactive against HIV-1 
p24 (clone 3H6.2; Epitope, Beaverton, OR) diluted 1: 50 in PBS-
BSA (1 %) followed by a biotinylated sheep-anti-mouse 19 antibody 
(Amersham Ltd., Amersham UK) diluted 1: 200 in PBS-BSA (1 %) 
and finally with a streptavidin-biotin-peroxidase complex (Dako-
patts A.S ., Copenhagen, Denmark). Positive staining was visualized 
using diaminobenzidine (Amersham Ltd., Amersham, UK) as a 
substrate. 
Transmission Electron Microscopy 106 cells were transferred 
to a microcentrifuge tube, washed twice in PBS and once in 0.1 M 
cacodylate-buffer, and resuspended in equal parts of glutaraldehyde 
and paraformaldehyde. After fixation for 30 min at room tempera-
ture specimens were post-fixed in4% OS04 for 1 h at room tempera-
ture, dehydrated in a graded series of ethanol, and infiltrated with 
and polymerized in EPON 812. Thin sections were stained with 
uranyl-acetate and lead citrate on grid and examined by transmis-
sion electron microscopy OEOL 1200 EX). 
Isolation of Cellular DNA and Southern Blotting 108 cells 
were lysed in 3 mllysis buffer and treated with proteinase K (10 
.ug/ml; Boehringer-Mannheim, FRG) for 2 h at 37°C. After three 
rounds of phenol-chloroform and one round of chloroform-isoamyl 
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Table I. HIV-l p24 Production by Epidermal Cells Enriched 1.000 ,--------------_______ ---. 
for Langerhans Cells and Cells Derived from Langerhans Cell 
Histiocytosis (LCH) 
Cells 
EC· 
Experiment 1 
Experiment 2 
Experiment 3 
LCH' 
Experiment 4 
Experiment 5 
p24, pg/ml' 
482 
415 
520 
745 
759 
• HIV-I p24 was determined 3 weeks after infection using an indirect ELISA tech-
nique. Samples with absorbence values two times greater than the cutoff value were 
consid ered positive. Given are mean values of triplicates . 
• Epidermal cell suspensions enriched for CDla+ LC were prepared as described in 
Materials alld Methods. Percentage of CD ta+ LC were 20 (experiment I), IS (experiment 
2) and 30 (experiment 3). 
, Cell suspensions derived from LCH contained 82% (experiment 4) and 85% (ex-
periment 5) CDla+ cells. 
alcohol extraction and subsequent ethanol precipitation, DNA was 
dissolved in 10 mM Tris-l mM EDTA (pH 8.0) and then digested 
with Hind III or Bgi II (Boehringer-Mannheim, FRG), respec-
tively. Fragments were separated on a 0.7% agarose gel and blotted 
onto a nylon membrane (Zeta Probe, Bio-Rad, Richmond, CA). 
Filters were hybridized to a 32P-Iabeled 9.0-kb SstI-insert from plas-
mid pBHI0-R3, a subclone of the HIV-l-specific recombinant 
clone ABHI0 [17]. After stringent wash cycles, filters were exposed 
to hyperfilm-MP (Amersham Ltd., Amersham, UK) at-70°C. All 
steps were performed according to standard protocols [18,19]. 
RESULTS 
LC-Enriched EC and LCH Cell Suspensions Can Be Produc-
tively Infected with HIV-l To test whether EC can serve as 
target cells for HIV-l, EC suspensions from HIV-l-seronegative 
individuals were inoculated with 100,000 cpm/ml reverse tran-
scri ptase HIV -1 WR-SK/86 ' an isolate derived from a skin biopsy of an 
AIDS patient suffering from Kaposi's sarcoma [9]. In three indepen-
dent experiments, we used EC suspensions containing 15%, 20%, 
and 30% cells bearing COla, an antigen that is expressed on epider-
mal LC [20]. KiM8- or CD3-positive cells were not detectable by an 
indirect immunofluorescence staining technique. Supernatants of 
EC c ultures were collected weekly for 10 weeks and screened for 
HIV -1 p24. Although we consistently failed to detect p24 during 
the first 2 weeks after HIV -1 infection, positive p24 values were 
recorded thereafter in each of the three experiments (see Table I) . 
Levels peaked 3 weeks after inoculation, remained constant for an-
other 3 weeks, and then declined. The addition of freshly isolated 
target cells (allogeneic MNP from HIV -1- seronegative donors) 
restored p24 production, indicating transmission of virus progeny 
(see Fig 1). Control experiments using EC adherent to collagen-
coated culture flasks and depleted for CDla+ cells never yielded 
detectable r24 values when incubated with identical strains and 
amounts 0 HIV-l (data not shown). 
In other experiments, we used tissue specimens from two patients 
suffering from LCH, a proliferative disorder ofLC, as evidenced by 
the tumor-cell expression of COla, CD4, MHC class II antigens, 
S-100 protein, and ATPase activity [21,22]. After removal of T 
lymphocytes by the negative selection procedure described inMateri-
als and Methods, resulting cell suspensions contained 80-85% 
CD la-bearing cells, but less than 1 % CD3- or KiM8-reactive cells. 
Results obtained showed that T ce ll -depleted LCH cell suspen-
sions shou ld be productively infected with HIV -1WR_SK/86 (Table I). 
Although the kinetics of HIV-l p24 production in LCH-derived 
CD la+ cells were similar to those seen in LC-enriched EC cultures, 
p24 levels were much higher in supernatants of HIV -1- infected 
LCH cell cultures as compared to HIV-infected LC-enriched EC 
cultures, most likely reflecting the higher numbers of target cells in 
LCH cultures. Analogous to the Ee cultures enriched for LC, the 
750 
250 
°O~---~--~==~==~4k=~5~==~6~~7~==~==~~-1~O--~11 
weeks after infection 
Figure 1. Kinetics of p24 production of in vitro infected epidermal cells 
enriched for CDla+ LC, LCH-derived CDla+ cells, or a mouse fibroblast 
ce ll line. Shown are the results of one representative experiment. EC 
enriched for LC (see experiment 1 in Table I, solid circles), CDla+ cells (LCH 
biopsy, experiment 4 in Table I, open circles), and L 929 cells (mouse fibro-
blasts, closed trimlgles) were exposed to HIV -lwR_sK/86 for 1 h at 37"C, washed 
three times, and cultured. Supernatants were screened weekly using an HIV-
1 p24-specific ELISA. Arrow, addition offresh target cells (allogeneic MNP). 
addition of target cells (allogeneic MNP) to LCH cultures with 
decreasing p 24 led to infection of the newly added cells and subse-
quently to enhanced p24 production (Fig 1). 
Rescue ofHIV-l from Epidermal Sheets ofHIV-1 Seroposi-
tive Donors Epidermal sheets from 23 HIV-1-seropositive 
donors were co-cultured with allogeneic MNP derived from a panel 
of HIV-l-seronegative individuals. Control cultures (n = 20) 
were composed of epidermal sheets and allogeneic MNP derived 
from HIV -1 - seronegative individuals. Supernatants of these cocul-
tures were screened for the presence ofHIV-l p24 weekly. Results 
obtained are summarized in Table II. Although we consistently 
failed to detect p24 during the first 2 weeks in any of the culture 
supernatants, substantial levels of p24 were encountered in superna-
tants of 12 of 23 co-cultures after a culture period of 3-5 weeks. 
This, together with the observation that addition of fresh MNP 
from HIV -1- seronegative persons to the co-cultures caused an in-
crease in p24levels (Fig 2), clearly indicates that 12 of23 co-cultures 
harbor infectious HIV-1. After consistent p24 production in these 
co-cultures was ascertained, we asked whether cell-free superna-
tants of three HIV -1 p24-positive co-cultures are capable of infect-
ing MNP monolayers from HIV -1- negative persons. In all three 
instances, we succeeded in serially passaging HIV-l over a time 
period of 6 weeks as evidenced by the detection of p24 antigen not 
only in culture fluids , but also in the cytoplasm of a large portion 
(60%) of adhering MNP (Fig 3a). 
In two independent experiments, we attempted to characterize 
HIV-1 isolates at the DNA level. For this purpose, high molecular 
weight DNA was isolated from two MNP cultures (HIV-1sv_Ec and 
H IV -1 DB-Ed each of which had been exposed to an epidermal sheet 
from a different HIV -1- infected person), subjected to restriction 
enzyme digestion, Southern blotting, and hybridization. Using a 
HIV -1- specific 9-kb SstI-insert, DNA from these two isolates gave 
strong hybridization signals and, in addition, revealed clear differ-
ences in the restriction patterns. These differences suffice to distin-
guish these isolates from each other and also from the prototype 
virus HIV-II1IB (Fig 4). 
Transmission of EC-Derived HIV-l to Different Cell Types 
In order to determine the target cell spectrum ofEC-derived HIV-1 
isolates, a variety of ontogenetically different host cells (MNP, 
PHA-stimulated T cells, T-cell lines H9 and Molt-3, and EBV-
transformed lymphoblastoid B-cell line 588-3) were exposed to 
cell-free supernatants of the EC-derived isolates HIV -lsv_Ec and 
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Table II. HIV -1 p24 Levels in Co-Cultures Between Epidermal Sheets (HIV -1- Seropositive Subjects) and Mononuclear Phagocytes 
(HIV -1 - Seronegative Donors) 
p24, pg/ mlb 
Stage' n Positive p24 (%) 1 Week 3 Weeks 5 W eeks 7 W eeks 
CDC II 4 2 (50) 7 30 110 65 
CDC III 9 4 (44) 4 25 115 67 
CDC IV 10 6 (60) 5 30 110 58 
Total 23 12 (54) 
Controls 20 0(0) 0 0 0 0 
II Center for Disease Control classification. 
• HIV·l p241cvels were determined using an indirect ELISA technique. Samples with absorbance values two times greater than the cutoff value were considered positive for HIV-l 
p24 anti gen . Given are mean values of triplicates. 
HIV -1 DB-EC for 1 h, washed, and cultured for 3 weeks. Culture 
fluids were harvested and assayed for the presence of p24 after 24 h 
and in weekly intervals thereafter. An increase in p24 could be 
detected already after 1 week, reaching its maximum after 3 weeks. 
Results obtained after a 3-week culture time showed that all cell 
types used could be readily infected as evidenced by the production 
of HIV -1 p24 (Fig 5). However, there was a difference in the level 
of p24 expression between the various target cell types. HIV -1 p24 
expression was most pronounced in Band T cells, whereas MNP 
secreted only moderate levels . Figure 5 shows the results of a repre-
sentative experiment using HIV -1 SV_EC • It is also noteworthy that 
none of the two isolates caused cell destruction and only rarely 
induced formation of multinucleated giant cells in any target cell 
type used (data not shown). 
Ultrastructural examination of T cells (H9) that had been ex-
posed to an EC-derived HIV -1 isolate (HIV -1 SV-Ecl revealed the 
presence of viral particles at different stages of maturation. Both on 
the cell surface and within cytoplasmic vacuoles we observed im-
mature ring-like particles and mature virions consisting of a lipid 
bilayer membrane and a central dense elongated nucleoid (Fig 6a). 
In addition, we frequently observed different stages of budding 
virus indicative of active VlfUS replication (Fig 6b). 
DISCUSSION 
In this study we have provided evidence that the epidermis is a 
target of HIV -1 infection. This evidence is based on the productive 
infection ofEC by HIV-1 and, conversely, on the successful isola-
tion of HI V -1 from the epidermis ofHIV-1-seropositive persons at 
120 ,--------------------------------------------------, 
90 
30 
o ~------------------------------------------------~ o 4 5 6 7 
weeks after infection 
10 11 
Figure 2. Kinetics of HIV -1 p24 production in a representative co-culture 
between an epidermal sheet from an HIV -1- positive patient and MNP from 
an HIV-1 -seronegative person (solid circles). Co-cultures were set up and 
maintained as described in Materials and Methods. Culture fluid was screened 
weekly for the presence of HIV -1 p24 by an indirect ELISA. Arrow, time of 
addition of fresh allogeneic MNP. Control co-cultures between MNP 
(HIV-l seronegative) and epidermal sheets from HIV-l -seronegative indi-
viduals served as control (solid triQllgles). 
a frequency that compares favorably with that reported for other 
tissues [14,23-25]. 
Our resu lts differ from those reported by other investigators. 
Kanitakis et al [12] failed to detect HIV-1 in epidermal specimens 
using immunofluorescence techniques or electron microscopy. We 
assume that the limited sensitivity of these methods account for the 
negative results, because our findings are supported by twO studies 
using the polymerase chain reaction (PCR) technique. Kanitakls: t 
al [26] detected HIV-1 DNA in 13 of21 epidermal specimens
d 
y 
PCR. Another study performed by Zambruno and co-workers e-
scribes the detection of HIV-1 proviral DNA by PCR in highly 
enriched (98% CD1a+ cells) epidermal LC derived from HIV-1 d 
seropositive individuals [27]. In contrast, Kalter et al [11] fou n 
HIV-1 DNA in only one of 12 epidermal sheets by PCR. Whether 
this discrepancy is due to different isolation procedures or other 
methodologic problems is unclear at the present time. 
A 
B 
Figure 3. Immunocytochemical detection of HIV-l p24 in MNP. M:t~ 
from HIV-l -seronegative donors grown in slide-flasks were r.xp.~e mal 
cell-free supernatant of a p24-positive co-culture between an cpl dernor) 
sheet (HIV-l-seropositive donor) and MNP (HIV-l-seronegatlve °der-(A) or to cell-free supernatant of a co-culture between MNP andan ep~eat 
mal sheet from HIV-l-negative persons (B). After a 1-h incubatl°1twing 
37°C, cells were washed three times and cultured for 3 weeks. Fo °mica1 
fixation in acetone, cells were further processed for immunocytoclfie acioi1 
staining using a p24-specific MoAb. Arrows, positive cells (magn1 C 
X200). 
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FiFure 4. Southern blot analys is of DNA fro m mononuclear phagocytes t ected with epidermal cell - derived HIV-1. MNP were either non-in-
lected (lalle 1) or infec ted with isolate HIV -1 SV.EC (lalle 3) and isolate HIV-
DB·EC (lalle 4), respectively. DNA from H9/HIV-I I1ID cells served as posi-~ve Control (lalle 2) . Ten micrograms cellular DNA was digested with either 
d Illd III or BgIlI, separated and blotted according to standard protocols, and 
etected by hybridization with the 32P-labeled Sstl-insert of the HIV -1-
specific probe pBHI0-R3. 
Although our data imply that EC can serve as targets for, as well as 
3 Source of, HIV -1 infection, the actual role of LC in this process 
b3nnOt be definitively evaluated from our experiments. Although 
oth the EC as well as the LC H suspensio ns contained substantial 
~urnbers of C D l a-bearing cells and were devoid if IF-detectable 
D3+ and KiM8-reactive cells before being exposed to HIV -1 , the 
Phesence of minute numbers of other C D 4-expressing leukocytes in 
t eSe cell suspen sions cannot be definitively excluded . 
. touthern blotting and hybridization of cellular DNA from MNP 
In ected with HIV -1 derived from epidermal sheets of two different Ind' . IVlduals not onl y proved the presence of HIV-l -specific se-
qUences, but also revea led differences in the restriction enzyme 
t~terns indicatin g that the isolates represent separa te entities. T wo 
-?en ved isolates tested so far showed no preferential target-cell 
specificity. In contras t to T-cell or macrophage isolates, which fre-
~ue ntly exhibit a res tricted cellul ar tropism [25,28], EC-derived 
~~us showed no lineage restrictio n and could be successfull y trans-
s· Itted to B cell s, T cells, and MNP. The latter cell type produced 
llgnlficantly low er amounts of p24, p robably refl ecting intracellu-
3r~ccumul ation of virus particl es in MNP [23,25J. 
e id he o.nly rare demo nstration of structural virus proteins in the 
pP enniS of HI V-I -seropositive persons [8] suggests that HIV - liS f~~:lent within th e epidermis in a latent form. This assumption is 
RN ler strengthened by results that compared HIV-l DNA versus 
\VI A expression in the epidermis of HIV -1 - seropositive subjects. 
be len ~SIng PC R, Kanitakis et al [26J found 62% of the samples to 
v' POSitive for HIV-1 DNA, but only 5% also expressed RNA. In k~o , latency mi ght be disrupted by a variety of inducers of HIV-l 
(e. OWn to act w ithin th e epidermis. Amon~ those a~e viral infections 
Ultg·, B erpes Simplex ViruS [29]) or phYSicochemica l stimuli [e.g., 
UV3vloiet B (UV -B) irradiation]. Evidence for a direct effect of 
th -B on HIV-1 has been presented by Valerie et ai, who showed 
cei{ ~V Irradi atio n activates the HIV -1 - LTR in a human epithelial 
lIle [30]. Exposure of epidermal ce lls to UV -B also leads to 
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Figure 5. p24 production of an epidermal cell - derived HIV -1 isolate in 
va rious target ce ll s. 5 X 106 ce lls [MNP, PHA-stimulated non-ad herent 
MNC, two T-cell lines (H9, Molt-3), and a EBV-positive B cell line (R588-
3)] were exposed to HIV-1 sv_Ec (100,000 cpm RT activity) for 1 h at 37"C, 
washed, and cultured. Shown are p24 levels in cel l-free supernatants after 3 
weeks using an ELISA technique. First two bars, non-infec ted control cell s. 
production of cytokines (IL-1 , IL-6, TNF-a [31]) , w hich are 
known to induce HIV-1 replication [32-34]. Expression of these 
cytokines may fin ally lead to reactivation of latent HIV -1 in EC. 
The actual consequences of activation and subsequ ent replication 
of HIV-1 within EC are large ly unknown. At the mo ment, some 
evidence exists that expression o f the HIV -1 tat pro tein w ithin the 
epidermis is of crucial importance for the development of Kaposi's 
sarcoma. Transgenic mice expressing HIV -1 tat develop derma l 
lesions resemblin g Kaposi's sarcoma and, interestingly, tat R N A 
expression has been shown to be res tricted to the epidermis of these 
animals [35]. The ro le of tat expressio n for the growth o f mesenchy-
mal cells has been furth er substantiated th rough in vitro experi-
ments by Ensoli and co-workers [36J. This group reported that tat 
acts as a growth factor fo r human cells derived fro m pul monary 
Kaposi's sarcoma. 
It is also conceivable that HIV -1 infection changes the secretory 
potential of EC. HIV- 1 may induce mediators li ke IL-1 , IL-6, or 
TNF-a that have positive effects on HIV-1 replication [32-34]. 
Altered production of cyto kines known to enhance virus expression 
might be crucial for the progression towards AIDS. C hanges in the 
secretory profil e o f EC by HIV -1 may also be respo nsible for the 
well-known phenomenon that HIV -1 infection apparently triggers 
the development of certain proliferative disorders of the skin (e.g., 
psoriasis, seborrheic dermatits [37,38]) . If one assumes that the ab-
no rmal growth of keratinocytes (KC) and infiltration by mononu-
A 
Figure 6. Demonstration of HIV-l (isolate HIV-1sv_Ecl within H9 cells 
(A) and budding from the surface (B, see arrow). Calibratio ll bar, 0.1 11111 • 
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clear cells seen in psoriasis is a consequence of upregulation of cer-
tain cytokines (e.g. TGF-a, IL-6 [39,40]), it is tempting to speculate 
that certain mediators of KC proliferation in psoriasis are also in-
duced by HIV -1. In fact, it has been shown that in serum samples 
from HIV -1- infected individuals as well as in supernatants from 
HIV-1-infected MNC, elevated levels of IL-6 can be detected 
[41,42]. Moreover, cytokines with chemotactic activity released by 
HIV-1-infected EC might attract additional target cells and 
thereby contribute to the spreading of the virus. Therefore, our 
finding that HIV -1 resides within, and can be rescued from, the 
human epidermis might have important implications for both the 
functional capabilities of epidermal cells as well as for virus dissemi-
nation. 
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